Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06422520
What this trial is testing

A First-in-Human Study of BGB-C354 Alone and in Combination With Tislelizumab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
BeOne Medicines 63
Testing effectiveness (Phase 2)UnknownNCT05906524
What this trial is testing

KD6001 in Combination With Anti-PD-1 Antibody±Bevacizumab in Patients With Advanced HCC and Other Solid Tumors

Who this might be right for
Advanced HCCOther Solid Tumors
Shanghai Kanda Biotechnology Co., Ltd. 85
Testing effectiveness (Phase 2)Active Not RecruitingNCT05945823
What this trial is testing

Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors

Who this might be right for
Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal CancerEsophageal AdenocarcinomaEsophageal Squamous Cell Cancer+2 more
Taiho Oncology, Inc. 53
Testing effectiveness (Phase 2)Ended earlyNCT04775680
What this trial is testing

Study of ADG106 In Combination With PD-1 Antibody In Advanced or Metastatic Solid Tumors and/or Non Hodgkin Lymphoma

Who this might be right for
Solid TumorNon Hodgkin Lymphoma
Adagene (Suzhou) Limited 25
Early research (Phase 1)Study completedNCT03340766
What this trial is testing

Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Who this might be right for
Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Amgen 31
Large-scale testing (Phase 3)Not Yet RecruitingNCT07277842
What this trial is testing

PD-1 + FOLFOXIRI vs CAPOX as Total Neoadjuvant Therapy for pMMR Low Rectal Cancer

Who this might be right for
Locally Advanced Low Rectal AdenocarcinomapMMR (Microsatellite Stable Rectal Cancer)
Sun Yat-sen University 382
Testing effectiveness (Phase 2)Study completedNCT03910660
What this trial is testing

A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.

Who this might be right for
Prostate CancerNeuroendocrine TumorsSmall Cell Carcinoma
BioXcel Therapeutics Inc 98
Testing effectiveness (Phase 2)Looking for participantsNCT06995105
What this trial is testing

Personalized Tumor Neoantigen mRNA Therapy for Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Zhejiang University 30
Testing effectiveness (Phase 2)Study completedNCT03459222
What this trial is testing

An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 229
Early research (Phase 1)Active Not RecruitingNCT05840224
What this trial is testing

Study of GS-4528 in Adults With Solid Tumors

Who this might be right for
Solid Tumor
Gilead Sciences 182
Early research (Phase 1)Ended earlyNCT02077959
What this trial is testing

Lenalidomide and Pidilizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Ohio State University Comprehensive Cancer Center 20
Not applicableActive Not RecruitingNCT06796231
What this trial is testing

Efficacy of PD-1 Monoclonal Antibody in the Treatment of Phaeohyphomycosis

Who this might be right for
Phaeohyphomycosis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 1
Testing effectiveness (Phase 2)UnknownNCT04612894
What this trial is testing

Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer

Who this might be right for
Thyroid Cancer
Fudan University 31
Testing effectiveness (Phase 2)Looking for participantsNCT06827236
What this trial is testing

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

Who this might be right for
Locally Advanced Breast CancerUnresectable Breast CarcinomaMetastatic Breast Cancer
BioNTech SE 380
Early research (Phase 1)Study completedNCT04201873
What this trial is testing

Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Jonsson Comprehensive Cancer Center 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07533305
What this trial is testing

Efficacy and Safety of QL1706 Combined With Nab-paclitaxel and Cisplatin as 1st Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
QL1706ESCCFirst-line Therapy
The First Affiliated Hospital of Henan University of Science and Technology 50
Early research (Phase 1)Study completedNCT03352531
What this trial is testing

Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK105 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Cancer
Akesobio Australia Pty Ltd 99
Not applicableNot Yet RecruitingNCT07440212
What this trial is testing

Clinical Study on Noninvasive Evaluation of Ivonescimab Antibody Distribution and Expression in Esophageal Cancer Patients by 89Zr-AK112 PET Imaging

Who this might be right for
Esophagus Cancer
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 50
Early research (Phase 1)WithdrawnNCT04799431
What this trial is testing

Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer

Who this might be right for
Pancreatic Cancer MetastaticColorectal Cancer Metastatic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Looking for participantsNCT05182957
What this trial is testing

Clinical Study on Anti-PD-1 Plus Lenalidomide and Azacitidine in Relapsed/Refractory Peripheral T-cell Lymphoma

Who this might be right for
Relapsed/Refractory Peripheral T-cell Lymphoma
The First Affiliated Hospital of Soochow University 31
Next Page